covid19

A significant discovery for global health A new disease has been discovered and named MIP-C (MDA5 autoimmunity and concurrent interstitial pneumonia with Covid-19). The research leading to this finding was conducted by an international…

Hair loss from Covid-19: the epidemiological curve from Covid is finally taking a dip, making us think it may be at its end

Russia, like the rest of the world, is confronted with new variants of Covid, in this case the one called 'Kraken'

The risk of developing myocarditis – an inflammation of the heart muscle – following a booster dose of the Pfizer COVID-19 vaccine is low, according to new research from Israel

China, the Covid nightmare is back: the industrial cities affected by the new coronavirus measures are Chengdu, Dalian, Guangzhou, Shenzhen and Shijiazhuang

Anti-inflammatories and Covid: Treatment with NSAIDs (non-steroidal drugs) at the onset of symptoms significantly lowers hospitalisation risk

The monoclonal antibody Nimotuzumab has demonstrated, during several years of clinical trials, its efficacy in the treatment of patients with cancer, and more recently in the use for the therapy of severe forms of COVID-19

The next step of the COVID-19 booster rollout will involve a “bivalent” vaccine that targets the ever-evolving Omicron variant. The vaccine isn’t here yet, but will likely be available in the fall

US study on Omicron positivity: 'Sars-CoV-2 could produce even more infectious variants'

Bivalent vaccine against Covid: the country is the first to approve Moderna's drug which tackles both the original Wuhan strain and the first variant of Omicron and will be part of the autumn booster campaign